BioWorld1h
Med-tech gainers and losers for Sept. 16-20, 2024
Copyright ©2024. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing Cookie Settings ...
BioWorld1h
Biggest gainers and losers for Sept. 16-20, 2024
Copyright ©2024. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing Cookie Settings ...
BioWorld16h
Holiday notice
In accordance with the publishing schedule, BioWorld Science will not be published on Tuesday, Sept. 24, 2024.
BioWorld18h
Recovery room: Skye, Corbus mend post-Novo CB1 weight-loss data
What the results might mean for the future of other developers in the cannabinoid receptor 1 (CB1) weight-loss arena came into question after Novo Nordisk A/S unveiled phase IIa findings with ...
BioWorld22h
CB1 weight-loss developers walloped by Novo’s monlunabant results
The trial investigated the efficacy and safety of a once-daily 10-mg, 20-mg, and 50-mg dose of monlunabant vs. placebo on body weight after 16 weeks in 243 people with obesity and metabolic syndrome.